Patents by Inventor Jarno Robin

Jarno Robin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10138290
    Abstract: The present invention relates to a process for the production of a haemostasis protein by continuous perfusion culturing of a cell culture in suspension, said cell culture expressing said haemostasis protein into said culture suspension, wherein the cell culture flows across a filter module, which filter module leads to a harvest port, the filter module having a mesh size of from 0.1 to 2.9 ?m allowing passage across of the haemostasis protein and wherein the flow across the filter module is an alternating tangential flow. The invention also relates to a protein produced by the process of the invention.
    Type: Grant
    Filed: October 5, 2011
    Date of Patent: November 27, 2018
    Assignee: Novo Nordisk Healthcare AG
    Inventor: Jarno Robin
  • Publication number: 20130244283
    Abstract: The present invention relates to a process for the production of a haemostasis protein by continuous perfusion culturing of a cell culture in suspension, said cell culture expressing said haemostasis protein into said culture suspension, wherein the cell culture flows across a filter module, which filter module leads to a harvest port, the filter module having a mesh size of from 0.1 to 2.9 ?m allowing passage across of the haemostasis protein and wherein the flow across the filter module is an alternating tangential flow. The invention also relates to a protein produced by the process of the invention.
    Type: Application
    Filed: October 5, 2011
    Publication date: September 19, 2013
    Applicant: NOVO NORDISK HEALTH CARE AG
    Inventor: Jarno Robin